Skip to main content
OpenTrials

Clinical trial condition

Macular Degeneration

Explore clinical trials studying Macular Degeneration. Study availability and eligibility vary by location and protocol.

853 public trials 106 recruiting studies
Refine in advanced search Browse all conditions

Macular Degeneration trial results

Completed

Visual Outcome in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy (PCV) Treated With Either Ranibizumab as Monotherapy or Combined With Verteporfin Photodynamic Therapy (vPDT)

NCT01846273

Conditions
Age-Related Macular Degeneration, Choroid Diseases, Choroidal Neovascularization, +10 more
Locations
  • Novartis Investigative Site Hong Kong
  • Novartis Investigative Site Nagoya, Aichi-ken, Japan
  • Novartis Investigative Site Nagoya, Aichi-ken, Japan
  • Novartis Investigative Site Fukuoka, Japan
View all 41 locations
View Trial Details
Completed

A Comparison of Ranibizumab and Aflibercept for the Development of Geographic Atrophy in (Wet) AMD Patients

NCT02130024

Conditions
Age-Related Macular Degeneration, Eye Diseases, Geographic Atrophy, +3 more
Locations
  • Novartis Investigative Site Albury, New South Wales, Australia
  • Novartis Investigative Site Brookvale, New South Wales, Australia
  • Novartis Investigative Site Chatswood, New South Wales, Australia
  • Novartis Investigative Site Hurtsville, New South Wales, Australia
View all 22 locations
View Trial Details
Completed

Treat & Extend Treatment With 0.5mg Ranibizumab vs Monthly Treatment With 0.5mg Ranibizumab

NCT01748292

Conditions
Eye Diseases, Macular Degeneration, Retinal Degeneration, +1 more
Locations
  • Palmetto Retina Center West Columbia, South Carolina, United States
  • Retina Consultants of Houston/The Medical Center Houston, Texas, United States
  • Retina Consultants of Houston/Katy office Katy, Texas, United States
  • Retina Consultants of Houston The Woodlands, Texas, United States
View Trial Details

Related conditions